astrazeneca_building_white

AZ launches lawsuit against former executive for defecting to GSK

May 17, 2017
Manufacturing and Production, Research and Development AZ, AstraZeneca, GSK, GlaxoSmithKline

AstraZeneca has launched a lawsuit against one of its former executives after he jumped ship to join rival pharma giant …

Bayer celebrates FDA priority review for investigational blood cancer drug

May 17, 2017
Research and Development, Sales and Marketing Bayer, FDA, blood cancer

Bayer has announced that its investigational blood cancer treatment copanlisib has been awarded priority review designation from the FDA, meaning …

T cells found to ‘acquire knowledge’ to take fight to metastatic cancer

May 17, 2017
Research and Development Cancer, T cell, immunotherapy

T cells are widely known as being crucial in the fight against cancer within the body but little was known, …

FDA demands new warnings for J&J diabetes drug over amputation risk

May 17, 2017
Manufacturing and Production, Research and Development, Sales and Marketing J&J, JJ, Johnson & Johnson, diabetes

Johnson & Johnson has found itself in deep water again over the potentially harmful effects of its products. This time …

Sangamo secures FDA’s Fast Track Designation for haemophilia candidate

May 17, 2017
Research and Development, Sales and Marketing FDA, Pfizer, Sangamo Therapeutics

Sangamo Therapeutics has announced that the FDA has granted its cDNA gene therapy candidate for haemophilia A Fast Track Designation. …

folder

Common treatment for MS revealed to have potential adverse reactions

May 16, 2017
Manufacturing and Production, Research and Development MS, multiple sclerosis

Beta interferons are a common treatment used to manage multiple sclerosis. The treatment works by reducing and preventing the inflammation …

New FDA Commissioner Gottlieb restructures workforce with product-based focus areas

May 16, 2017
Manufacturing and Production, Sales and Marketing FDA, Scott Gottlieb

Scott Gottlieb has wasted no time since his appointment to the role of FDA Commissioner last week. As one of …

European Commission targets Aspen over 1,500% price hikes

May 16, 2017
Manufacturing and Production, Sales and Marketing European Commission, aspen

The European Commission (EC) has opened its first investigation over drug pricing following alleged hiking by pharma company Aspen, which …

ionis

Patient death sparks safety worries in Ionis trial

May 16, 2017
Manufacturing and Production, Research and Development Ionis Pharmaceuticals

Ionis Pharmaceuticals announced the results from a Phase 3 trial of its drug to treat patients with familial amyloid polyneuropathy …

cuba

Cuba looks to begin trials of new neuroprotective treatment for Alzheimer’s

May 16, 2017
Manufacturing and Production, Research and Development Alzheimer's, Cuba, dementia

The health care system in Cuba is widely held up to be a model of innovation; despite severe economic  sanctions …

GSK mulls $8 billion healthcare consolidation deal

May 15, 2017
Sales and Marketing GSK, Novartis

When GSK and Novartis first agreed their business swap and healthcare joint venture, it was seen as marking a shift …

brexit_flag

Brain drain: The experts the UK may lose due to Brexit

May 15, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing brexit

The regulatory and drug approval process is destined to change once the UK leaves the EU. The problem is, nobody …

mosquito

Malaria expected to be eradicated from 15 Indian states by 2020

May 15, 2017
Research and Development, Sales and Marketing India, antimalarial drug resistance, malaria

In good news in the fight against antimalarial drug resistance, the Director of the National Vector Borne Disease Control Programme …

India to immunise five million using Pfizer pneumococcal disease vaccine

May 15, 2017
Sales and Marketing 13-valent Pneumococcal Conjugate Vaccine, India, PCV 13, Pfizer

An Indian immunisation programme will make use of Pfizer’s 13-valent Pneumococcal Conjugate Vaccine (PCV 13) to treat around 5.15 million, …

headquarters_2_web

Lilly’s migraine drug succeeds in Phase 3 trials

May 15, 2017
Research and Development, Sales and Marketing Eli Lilly, migraines

Eli Lilly announced the successful results of three Phase 3 trials examining the benefits of its drug, galcanezumab, in patients …

fdaoutsideweb

FDA green-lights Alembic’s cholesterol drug

May 15, 2017
Sales and Marketing Alembic, FDA, cholesterol

Alembic Pharmaceuticals has announced that its fenofibric acid delayed-release capsules have been approved by the FDA for reducing high cholesterol …

IFPMA appoints new Assistant Director General

May 12, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing IFPMA

The International Federation of Pharmaceutical Manufacturers and Associations has followed up its appointment of Thomas Cueni as Director General by …

top_ten_1

Top Ten most popular articles on Pharmafile.com this week

May 12, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biggest news, biggest stories, pharma news, pharmaceutical news, top ten

It’s been a bad week for several large pharmaceutical companies this week, with some major failures in clinical trials that …

shutterstock_274590824

China threatens prison time and death penalty to fight fraudulent trial data

May 12, 2017
Medical Communications, Research and Development, Sales and Marketing China

In a drastic move to help solve its notorious problem with fraudulent clinical trial data, China has introduced a policy …

aedes_aegypti_mosquito

Brazil declares end to Zika virus emergency

May 12, 2017
Medical Communications Brazil, Vaccine, Zika, Zika virus

Brazil has declared that the national emergency over the Zika virus threat is over, after there was a 95% drop …

The Gateway to Local Adoption Series

Latest content